🦊/Investors

LYFE Capital

Venture capital

Menlo Park · Seed–Late Stage · 16 people tracked

Also known as LYFE CAPITAL GLOBAL PARTNER LIMITED · LYFE CAPITAL INVESTMENT MANAGEMENT (HONG KONG) LIMITED · LYFE CAPITAL INVESTMENT MANAGEMENT (SHANGHAI) CO., LTD. · LYFE CAPITAL INVESTMENT MANAGEMENT LIMITED · LYFE U.S LLC

Find your way into LYFE Capital

1,507 people in our graph share verified history with the LYFE Capital team — schools, employers, funds. One of them is your warm intro.

Birgitteunlockedknows Fong Ming Koh · together at UC San Diego (overlapped)
×2knows the team · via Bain Capital
knows the team · via Duke University
knows the team · via University of California, San Francisco
×3knows the team · via Case Western Reserve University
knows the team · via Raffles Institution
Fox Verdict
Sign up to see your fit

Investment thesis

LYFE Capital is a healthcare investment platform led by investment veterans and operators who have navigated multiple market cycles. Operating from five global offices in Asia and the United States, the firm targets critical healthcare supply chain assets, specialized product platforms, and next-generation R&D services. Its aim is to help these companies grow significant and resilient revenues by tapping into global mature markets.

Source: firm website, verified Sep 15, 2026.

Stage
Seed–Late Stage
HQ
Menlo Park, US
Leads rounds
Follows
Instruments
Equity
Founded
2015
AUM
$2B
VC funds
1
Tracked investments
24
Acquisitions
1

Team · 16 people

from the firm's website & public directories

Founder mafia

2 people who came through LYFE Capital went on to found or lead other companies.

What they invest in

from 13 of 24 portfolio companies

Biotech ×11Healthtech ×10Medical Devices ×4Deep Tech ×3Advanced Manufacturing ×2Digital Health ×2Wellness & Fitness ×2AI & Machine Learning ×1

HQs:United States×5China×2Taiwan×1

Investments · 24 tracked

founders shown can be your intro path

By year:2025 · 12024 · 12021 · 12020 · 14 dated

Cytotronicscytotronics.cominMar 2024✓ verifiedacquired by Axion BioSystems · Jan 2026

Cytotronics develops Pixel, a semiconductor-to-live-cell interface platform that measures cell viability, morphology, electrophysiology, and metabolism at single-cell resolution across any cell type or 3D organoid system.

BiotechDeep TechSemiconductorsBoston, US

Jeffrey Abbott(Co-Founder & CEO)inDuane Sword(Co-Founder & CBO)inDonhee Ham(Scientific Co-Founder)inHongkun Park(Scientific Co-Founder)Vince (Wenxuan) Wu(Founder)inWenxuan Wu(Executive Officer, Director)

Co-investorsAnzu PartnersBantam GroupDraper AssociatesBoxOne Ventures

Guokangguokang.com✓ verified

Guokang is a Chinese health management company providing private-doctor and corporate health management services, primarily to executives and directors of large enterprises, along with health insurance brokerage and an online health-management SaaS platform.

Digital HealthHealthtechSaaSWellness & FitnessShenzhen, CN

杨华山(Chairman & CEO)Yang Huashan(Chairman & CEO)

Co-investorsQiming Venture Partners

Iecureiecure.com✓ verified

iECURE is a clinical-stage biotechnology company developing in vivo genome editing therapies that insert a functional copy of a gene into a patient's genome to treat rare, life-threatening genetic diseases in children.

BiotechHealthtechMedical Devices

James M. Wilson(Scientific Founder)Joseph Truitt(CEO & Board Member)inPaul Firuta(COO)inAlex Monteith(Chief Business Officer)David Garrett(CFO)inGabriel M. Cohn(Chief Medical Officer)in

Co-investorsOrbiMedVersant Ventures

Bora Pharmaceuticalsbora-corp.comin

Bora Pharmaceuticals is a pharmaceutical services company offering CDMO (contract development and manufacturing) for both small molecule and large molecule/biologics products, alongside its own drug development focused on specialty pharma and rare diseases.

Advanced ManufacturingBiotechHealthtech

Bobby Sheng(Founder)in

HiFiBiO Therapeuticshifibio.comin𝕏

HiFiBiO Therapeutics develops immunotherapies for patients with high unmet medical needs, using its Drug Intelligence Science (DIS) platform that combines single cell technology with AI/ML analytics.

AI & Machine LearningBiotechHealthtech

Liang Schweizer(Founder)in

Co-investorsB Capital GroupB4 CapitalTrinity Innovation Bioventure SingaporeIDG CapitalLegend CapitalSequoia Capital

IMEIK Technologyimeikglobal.com

An enterprise that develops and commercializes biomedical materials and biopharmaceutical products, including Class III and Class II medical devices, dermal fillers, facial threads, and proteins/peptides for medical aesthetics, dermatology, surgery, metabolic disease, and professional skincare.

BiotechHealthtechMedical DevicesWellness & FitnessBeijing, CN

Molecular Assembliesmolecularassemblies.comJul 2020

Molecular Assemblies uses a Fully Enzymatic Synthesis (FES) technology to produce long, pure, and accurate synthetic DNA oligonucleotides, up to 400 bases, without post-synthesis purification.

BiotechDeep TechNew MaterialsSan Diego, US

J. William Efcavitch, Ph.D.(Treasurer and Chief Scientific Officer)Michael J. Kamdar(President, Chief Executive Officer and Secretary)

BoardDavid Hwang(Director)Larry Stambaugh(Chairman of the Board of Directors)John Nicols(Director)Todd Peterson(Director)

Co-investors11.2 CapitalDCVC (Data Collective)iSelect FundRising TideAlexandriaArgonautic Ventures+2 more

Neurona Therapeuticsneuronatherapeutics.cominApr 2025 · $102M

Neurona Therapeutics is a clinical-stage biotherapeutics company developing allogeneic neural cell therapies to treat chronic disorders of the nervous system.

BiotechDeep TechHealthtechSouth San Francisco, US

Cory Nicholas(Executive Officer, Director, Promoter)inJames Stutz(Chief Financial Officer and Chief Business Officer)inCatherine Priest(Chief Development Officer)inGautam Banik(Chief Technology Officer)inEduardo Dunayevich(Chief Medical Officer)inArnold Kriegstein(Director)

Co-investorsBerkeley FrontierIaso VenturesThe Column GroupYsios CapitalAlexandriaFidelity Investments+7 more

Noahmednoahmed.comin𝕏

Noah Medical develops robotic and software solutions for diagnostic bronchoscopy procedures, designed to enable earlier lung cancer diagnosis with improved accuracy.

HealthtechMedical DevicesRoboticsSilicon Valley, US

Jian Zhang(Founder & CEO)Enrique RomoinFrank Grilloin

Co-investors1955 CapitalChina Growth CapitalProsperity7 VenturesShangBay Capital LLC

Nucleixnucleix.comin𝕏Apr 2021 · $55M

Nucleix is a healthcare company developing diagnostic technology based on DNA/nucleic acid analysis for cancer detection.

BiotechDigital HealthHealthtechMedical Devices

Eli Frydman(President EMEA)

Co-investorsGefen CapitalOrbiMedRA CapitalBlackRockLilly Asia VenturesSands Capital Ventures

Sciwindsciwindbio.com

Sciwind Biosciences is a commercial-stage biopharmaceutical company that discovers, develops, and delivers therapeutics focused on metabolic and weight management conditions, serving patients globally.

BiotechHealthtech

ST Pharmstpharm.co.krin

ST Pharm is a contract development and manufacturing organization (CDMO) producing active pharmaceutical ingredients, with a focus on gene therapy and nucleic acid technologies spanning oligonucleotides to xRNA.

Advanced ManufacturingBiotechHealthtech

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

BrightechChemLexCleveland DiagnosticsEDGEEdge MedicalFong's EngineeringJeisis MedicalKali TherapeuticsKangji MedicalMediLinkNoahProfound Bio

Exits · 1

1 acquisitions

Cytotronicsacq. by Axion BioSystems

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has LYFE Capital made?
LYFE Capital has 24 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
What stage does LYFE Capital invest at?
LYFE Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does LYFE Capital focus on?
LYFE Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices, Robotics, Sector Agnostic.
Where is LYFE Capital located?
LYFE Capital is headquartered in Menlo Park, US.
Does LYFE Capital lead rounds?
LYFE Capital typically participates in rounds rather than leading them.
Who does LYFE Capital co-invest with?
LYFE Capital most often shares deals with 1955 Capital, B Capital Group, B4 Capital, among 10 tracked co-investors.

Similar investors

Featured in lists